Recruitment - Articles

When not doing 'insane sports', Amgen's Europe chief Rolf Hoffmann is battling big pharma
At Amgen, the world's largest biotechnology company, health is not just the way people make their money. It is also a serious business in employees' personal lives. The California-based company has America's largest cycling club and if you want to get into the gym at lunchtime but have not booked a spot on the treadmill, forget about it. Even by this company's energetic standards, Rolf Hoffmann, head of Amgen's international operations, takes his exercise more seriously than most. A former Olympic swimmer for Germany, Mr Hoffmann is a self-confessed addict to "iron-man and insane, long-distance events". This summer, the 47-year-old will compete in a 200 mile race across Switzerland - one of Amgen'…

This summit aims to provide both strategic and practical information that will ensure that organisations can prepare for and survive what is now considered to be the inevitable pandemic. Professor Hugh Pennington from the Department of Medical Microbiology at University of Aberdeen will repeat his warning that, “Only one thing is certain and that is that there will be a pandemic.”
The topics to be covered at the Summit will stress that comprehensive plans must cover seemingly diverse aspects such as legal policy, staff travel, quarantine arrangements, as well as controlling rumour, speculation and scaremongering that can easily rage out of control If you or your team wish to attend , you can email me or register through one of the options below. You can view the programme and…

A new report estimates that there will be approximately 84,000 cases of adult and childhood leukemia in the world's seven major pharmaceutical markets in 2006. Acute leukemias will account for 43% of these cases, and, although this market is relatively small compared to other cancer types, the clear unmet needs and regulatory incentives should help encourage drug makers.
Rlapse rates high Unfortunately, relapse rates following treatment for AML and ALL are high, and current treatments offer little chance of long-term survival for most patients. While developmental drugs in this area have the opportunity to garner orphan drug designation and fast track approval status by the FDA, given the niche nature of treatments for this form of cancer, the return on investment for developers of novel…

This Conference will provide a platform for intellectual discourse in order to answer these questions and to discuss other pressing issues regarding the pharmaceutical industry in China in particular, and the world in general. Opportunities and challenges within the whole value chain, from research and development down to sales and marketing will be discussed and solutions put forward for the benefits of attendees.
WHAT YOU WILL TAKE AWAY FROM THIS CONFERENCE We believe that the quality of a conference program comes from listening to the requests and advice given by our target market. We pride ourselves in providing the most-up-to date subject matter suggested by the market in an environment that is conducive to networking and learning. At this event, you will have the unique opportunity…

This month we try to unravel the mystery (or some may say misery) of assessment centres and interview techniques. As the job market becomes more competitive companies are tending to conduct assessment centres for job placement and also for development purposes.
These assessments may involve psychometric tests. Many of us may have experienced assessment centres when applying for new positions however there are few people who attend these centres who really enjoy them. For some the assessment centre can be a barrier for them in applying for a new job. Psychometric and personality tests are often the tests that people are most wary of as employees outside of HR do not generally understand why they are used. If you want to understand more about assessment centres and how psychometric tests w…

I recently ran a quick poll on PharmiWeb, to determine what level of awareness there was for RSS (really simple syndication). So...
According to our quick RSS survey, 68% of respondents had no idea what it was or how to use it. This is a shame as we, and many other sites in the pharmaceutical industry are  providing them.So lets start with "what is RSS?" - essentially its a data standard that allows data to be made available in a format that can be easily picked up by a simple reader you install on your computer. In reality there are several standards, but most reader software reads them all. What this means to you is that by installing a small piece of software, you can elect to collect news (or whatever information sites make available) from across the web, and collect them into a si…

Why ? Decision makers were not aware of the ROI that can have a search engine marketing strategy.
Over the last 8 years, Pharmaceutical companies and groups did not consider any move that attracts and recruit leads in the best cost effective way. Why ? Decision makers were not aware of the ROI that can have a search engine marketing strategy. elias KAI www.Google-kai.com

The 2nd international exhibition and conference event focussed exclusively on the theme of outsourcing in the research and development of new medicines. Companies both large and small are adopting this increasingly popular business strategy.
The 2nd international exhibition and conference event focussed exclusively on the theme of outsourcing in the research and development of new medicines. Companies both large and small are adopting this increasingly popular business strategy.  Pabord is relevant to service providers and R&D organisations active across the entire discovery and development chain from lead generation to product registration

Your cv is one of the most important documents you will ever write, particularly in the new internet era of recruitment. With job application becoming easier it follows that more applications are goin
Your CV is one of the most important documents you will ever write, particularly in the new internet era of recruitment. With job application becoming easier it follows that more applications are going to be received for each position advertised and this places even more emphasis on the recruiter to filter all of these applications. As a result many recruiters employ blanket rules in the first stage of whittling down the number of applicants for a post until they are in a position to invite people for interview. It is here where the most minor things can let you down, simple spelling mistakes,…

If Sales Force Effectiveness is high on your agenda in the current climate, then don’t miss Pharma IQ’s Next Generation Pharmaceutical Sales Strategies event in June. Learn from speakers who have effectively increased their sales force ROI & successfully implemented alternative options to drive sales effectiveness.
If Sales Force Effectiveness is high on your agenda in the current climate, then don’t miss Pharma IQ’s Next Generation Pharmaceutical Sales Strategies event in June.  Learn from speakers who have effectively increased their sales force ROI & successfully implemented alternative options to drive sales effectiveness.  Why should you attend this event?  Including real industry case studies from Pfizer, Novartis, Orion Pharma, Takeda UK, Chiesi Farmaceutic…

Back in 2000, I was really, really excited. Had I got a date with Kylie Minogue? No. Had West Ham won the Champions League? Not likely. I was excited because I thought I had discovered the best investment sector in the market -- life sciences.
Back in 2000, I was really, really excited. Had I got a date with Kylie Minogue? No. Had West Ham won the Champions League? Not likely. I was excited because I thought I had discovered the best investment sector in the market -- life sciences. How could I lose? The potential of new technologies such as genomics and monoclonal antibodies appeared to be huge. On top of that, I knew that most people in the developed world were living longer and becoming richer too. Buying shares in drugs companies was close to a sure thing! As time went on, I began…

PharmiWeb recently asked Merck to provide some insight into what it was like to work as a sales rep for their company. Rather than just telling us what they thought we wanted to hear, they took the more open approach of asking their team for "real life" comments, and then gave us their rather impressive raw responses, with no additions or changes.
1. OPPORTUNITIES The small size of the company means that everyone is recognised as a person who plays a vital role in the success of their territory and region, and individual successes, however small, are noted. Merck is also constantly giving me opportunities to progress within the company.We have an excellent portfolio, products that save lives and that I genuinely believe in.Autonomy and recognition for sales successes.Supportive managers, w…

ICON’s core competency is project management, built up over the last fifteen years managing complex projects and underpinned by comprehensive and consistent processes which conform to the ISO9001:2000 quality certification.
1. Can you describe ICON for me in a single sentence? ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.2. How and when did ICON start? ICON was founded in 1990 by Dr. John Climax and Dr. Ronan Lambe. Originally launched with just five staff all based in Dublin, we grew organically for our first 10 years, making our first acquisition in 2000. We now have 3000 staff operating from 41 offices across 27 countries. 3. Why do you think ICON is so successful?The quality of our peop…

A glimpse of the broad-based, versatile business strategy that has enabled Abbott to combine dynamic growth with long-term stability.
A glimpse of the broad-based, versatile business strategy that has enabled Abbott to combine dynamic growth with long-term stability. Abbott had an excellent 2004, according to its CEO, Miles White: it achieved double-digit growth in both of its business groups. How was this managed in the face of what is perhaps the most difficult business environment the healthcare industry has ever faced– and one that is not expected to improve significantly in the foreseeable future? How has Abbott navigated this extremely difficult environment while simultaneously transforming the company into anorganisation better prepared to overcome the same challenges in the futu…

Abbott recently had the largest gain in reputation of any company in its industry when Fortune magazine ranked it number three in the magazine’s list of the most admired companies in the United States – Fortune’s highest ranking for Abbott since 1989. How was this achieved and what factors led up to it?
Abbott recently had the largest gain in reputation of any company in its industry when Fortune magazine ranked it number three in the magazine’s list of the most admired companies in the – Fortune’s highest ranking for Abbott since 1989. How was this achieved and what factors led up to it? In April 2005, Miles White, Abbott’s CEO, summed up the previous year’s performance in one word – “Excellent”. Five years ago, it was clear that the company would have to reposition itself yet again in…

The early part of a New Year can be a good time to focus on your career and your personal goals for the coming year. You may be thinking of either looking for promotion within your current company or you may be thinking of applying to another company. Is there anything that you can do in order to increase your chances of being offered your dream job? The answer is yes, however it does need considerable input from you...
Of course before getting that crucial job offer there are the following hurdles to clear; your CV requires careful writing, there is pre-interview research to do and then the interview process itself to go through. You could stumble at any one of these hurdles. Checking these simple tips from the Vacancy Management Company can help you improve your chances of being offered…

A new study shows the oral iron-chelator Ferriprox (deferiprone) prevents patients with thalassaemia experiencing heart complications and dying of heart failure. Patients with the condition require frequent blood transfusions with the unwanted effect of excess iron that can build up in organs and endocrine glands. Iron overload in the heart can produce fatal complications so effective treatment with iron chelation therapy to remove iron is vital. The finding that an oral treatment achieves bett
A new study shows the oral iron-chelator Ferriprox (deferiprone) prevents patients with thalassaemia experiencing heart complications and dying of heart failure.  Patients with the condition require frequent blood transfusions with the unwanted effect of excess iron that can build up in organs…

There is little mystery about what the next few years hold for the clinical research industry –it comes down to one word: speed. It is all about speed. The gauntlet has been thrown down and the companies that are able to demonstrate an effective and consistent approach to truncating the timeline of clinical trials will be very successful.
By: Brian S. Robinson i3, Vice-President, Global Marketing  www.i3global.com There is little mystery about what the next few years hold for the clinical research industry –it comes down to one word: speed. It is all about speed. The gauntlet has been thrown down and the companies that are able to demonstrate an effective and consistent approach to truncating the timeline of clinical trials will be very successful. Speed is not a capabili…

Perhaps the greatest challenge facing global drug development is the scarcity of new clinical research professionals entering the industry, bringing refreshing energy and ideas to their work, but lacking practical experience. Those involved in recruiting CR staff will be aware of this shortage and that experienced employees are seeking greater career management/development and rapid progression.
Bill McHale and Iain Jessup – i3 Pharma Resourcing Perhaps the greatest challenge facing global drug development is the scarcity of new clinical research professionals entering the industry, bringing refreshing energy and ideas to their work, but lacking practical experience.  Those involved in recruiting CR staff will be aware of this shortage and that experienced employees are seeking gr…

Electronic Data Capture (EDC), three little words that can divide the clinical research community like few others. To some, EDC is a panacea for all the troubles and rising costs of the clinical development process, whilst to others it spells broken promises, and forms the butt of many less than flattering anecdotes.
Electronic Data Capture (EDC), three little words that can divide the clinical research community like few others. To some, EDC is a panacea for all the troubles and rising costs of the clinical development process, whilst to others it spells broken promises, and forms the butt of many less than flattering anecdotes. But what is the reality, and where is the border between the promise of providers and the expectation of end users? This article is not designed to provide d…